The insurance industry is at a pivotal moment, grappling with the transformative potential of artificial intelligence while navigating the ethical challenges it presents. As insurers strive to enhance ...
Early-Stage Breast Cancer in Women Younger Than 50 Years: Comparing American Joint Committee on Cancer Anatomic and Prognostic Stages With Partitioning Around Medoids Clusters in SEER Data Large ...
Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer The authors present a score that ...
Every week, I see another headline about an AI model achieving “96% accuracy” in healthcare or finance. The press releases are exciting, the demos look impressive and stakeholders are eager to deploy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results